The Impact of Germline BHD Mutation on Histological Concordance and Clinical Treatment of Patients With Bilateral Renal Masses and Known Unilateral Oncocytoma
- 30 June 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 185 (6), 2050-2055
- https://doi.org/10.1016/j.juro.2011.02.051
Abstract
Managing patients presenting with oncocytoma in the setting of bilateral renal masses is a challenging scenario. Nevertheless, pathologic concordance of oncocytic neoplasm in one kidney with tumors in the contralateral kidney is not known. We aim to evaluate the influence of germline Birt-Hogg-Dubé (BHD) mutation on concordance rates to assist in management of these patients. We reviewed records of the NIH patients between 1983 and 2009 having bilateral renal masses, known pathology bilaterally, and presence of oncocytoma or oncocytic neoplasm in at least one kidney. The presence of oncocytoma or oncocytic neoplasm in two renal units was considered concordant. Demographic, pathological and clinical data were collected. The patient population consisted of 40 patients: 23 with BHD and 17 patients without diagnosis of BHD. Patients with BHD were younger (p<0.01) but there were no other differences between two groups. However, patients with BHD had a statistically lower histologic concordance between bilateral masses when compared to patients without the diagnosis of BHD (Fisher's exact test, p<0.01). Additionally, the subgroup of patients (n=8) without BHD who had multifocal renal masses demonstrated 100% oncocytoma concordance between renal units. In patients with bilateral renal masses BHD patients have significantly lower histologic concordance rates compared to patients without BHD. Patients with BHD should be monitored and managed differently than patients without detected genetic mutations, especially those with multifocal oncocytomas. Genetic testing for BHD should be considered in the algorithm for management of patients with bilateral renal masses and known oncocytoma.Keywords
This publication has 30 references indexed in Scilit:
- The genetic basis of kidney cancer: a metabolic diseaseNature Reviews Urology, 2010
- Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2Proceedings of the National Academy of Sciences of the United States of America, 2009
- Genetic Basis of Bilateral Renal Cancer: Implications for Evaluation and ManagementJournal of Clinical Oncology, 2009
- Pathologic Concordance of Sporadic Synchronous Bilateral Renal MassesUrology, 2008
- BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reportsJournal of Medical Genetics, 2008
- Multifocal Renal Cortical Tumors: Frequency, Associated Clinicopathological Features and Impact on SurvivalJournal of Urology, 2004
- The Genetic Basis of Cancer of the KidneyJournal of Urology, 2003
- The Effect of Bilaterality, Pathological Features And Surgical Outcome in Nonhereditary Renal Cell CarcinomaJournal of Urology, 2003
- Familial and Sporadic Renal Oncocytomas – A Comparative Molecular–Genetic AnalysisEuropean Urology, 2001
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987